271 related articles for article (PubMed ID: 35909315)
1. p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic Alzheimer's disease mice.
Luo Q; Schnöder L; Hao W; Litzenburger K; Decker Y; Tomic I; Menger MD; Liu Y; Fassbender K
Aging Cell; 2022 Aug; 21(8):e13679. PubMed ID: 35909315
[TBL] [Abstract][Full Text] [Related]
2. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice.
Quan W; Luo Q; Hao W; Tomic I; Furihata T; Schulz-Schäffer W; Menger MD; Fassbender K; Liu Y
Glia; 2021 Aug; 69(8):1987-2005. PubMed ID: 33934399
[TBL] [Abstract][Full Text] [Related]
4. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
5. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.
Gee MS; Son SH; Jeon SH; Do J; Kim N; Ju YJ; Lee SJ; Chung EK; Inn KS; Kim NJ; Lee JK
Alzheimers Res Ther; 2020 Apr; 12(1):45. PubMed ID: 32317025
[TBL] [Abstract][Full Text] [Related]
6. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ).
Bachstetter AD; Xing B; de Almeida L; Dimayuga ER; Watterson DM; Van Eldik LJ
J Neuroinflammation; 2011 Jul; 8():79. PubMed ID: 21733175
[TBL] [Abstract][Full Text] [Related]
7. P38α-MAPK phosphorylates Snapin and reduces Snapin-mediated BACE1 transportation in APP-transgenic mice.
Schnöder L; Tomic I; Schwindt L; Helm D; Rettel M; Schulz-Schaeffer W; Krause E; Rettig J; Fassbender K; Liu Y
FASEB J; 2021 Jul; 35(7):e21691. PubMed ID: 34118085
[TBL] [Abstract][Full Text] [Related]
8. IKKβ deficiency in myeloid cells ameliorates Alzheimer's disease-related symptoms and pathology.
Liu Y; Liu X; Hao W; Decker Y; Schomburg R; Fülöp L; Pasparakis M; Menger MD; Fassbender K
J Neurosci; 2014 Sep; 34(39):12982-99. PubMed ID: 25253847
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
Front Immunol; 2021; 12():628156. PubMed ID: 34046031
[TBL] [Abstract][Full Text] [Related]
10. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
[TBL] [Abstract][Full Text] [Related]
11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
12. Early chronic suppression of microglial p38α in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
Braun DJ; Frazier HN; Davis VA; Coleman MJ; Rogers CB; Van Eldik LJ
PLoS One; 2023; 18(5):e0286495. PubMed ID: 37256881
[TBL] [Abstract][Full Text] [Related]
13. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
14. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
15. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
16. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model.
Blacher E; Dadali T; Bespalko A; Haupenthal VJ; Grimm MO; Hartmann T; Lund FE; Stein R; Levy A
Ann Neurol; 2015 Jul; 78(1):88-103. PubMed ID: 25893674
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1.
Schnöder L; Hao W; Qin Y; Liu S; Tomic I; Liu X; Fassbender K; Liu Y
J Biol Chem; 2016 Jan; 291(5):2067-79. PubMed ID: 26663083
[TBL] [Abstract][Full Text] [Related]
19. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.
Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY
J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466
[TBL] [Abstract][Full Text] [Related]
20. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
